14-day Premium Trial Subscription Sign Up For FreeGet Free

$19.48 (-2.16%)

Volume: 251k

Closed: Nov 29, 2021

Hollow Logo Score: -4.929

Amphastar Pharmaceuticals Stock Forecast

$19.48 (-2.16%)

Volume: 251k

Closed: Nov 29, 2021

Score Hollow Logo -4.929
Which way will AMPH go? Request
Key Stats
P/E Ratio 25.83
Beta 0.51
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 46 and the stock is currently not being overbought or oversold

Evaluation of Amphastar Pharmaceuticals stock downgraded after the last trading session.
(Updated on Nov 29, 2021)


Sell candidate since 2021-11-29

The Amphastar Pharmaceuticals stock price fell by -2.16% on the last day (Monday, 29th Nov 2021) from $19.91 to $19.48. and has now fallen 4 days in a row. During the day the stock fluctuated 8.43% from a day low at $19.21 to a day high of $20.83. The price has fallen in 6 of the last 10 days and is down by -8.54% for this period. Volume has increased on the last day by 131 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 251 thousand shares were bought and sold for approximately $4.90 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.98% during the next 3 months and, with a 90% probability hold a price between $20.92 and $24.02 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The Amphastar Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $20.45 and $19.82. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -8.54%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Amphastar Pharmaceuticals finds support from accumulated volume at $18.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 8.43%. For the last week, the stock has had a daily average volatility of 4.71%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Amphastar Pharmaceuticals stock A Buy?

The Amphastar Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Amphastar Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.929

Predicted Opening Price for Amphastar Pharmaceuticals of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$19.84 $19.48 (Undervalued)
Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Jul 20, 2021 "Northland Securities" gave "$23.00" rating for AMPH. The price target was set to $20.43+2.0%.

Volatility and Risk
Daily Average Volatility: 4.71 %
Overall Risk: Very High High Medium Low Very Low
Volatility
4.71 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $20.76
Price: $19.48
Support: $18.68

AMPH Insider Trading Show all Trades

INSIDER POWER

0.850

Last 100 transactions
Buy: 464 978 | Sell: 547 028 (Shares)
Date Action Amount Person Type
Nov 22, 2021 Sell 5 000 Prins Richard K Stock Option (right to buy)
Nov 22, 2021 Sell 5 000 Prins Richard K Common Stock
Nov 22, 2021 Buy 5 000 Prins Richard K Common Stock
Nov 11, 2021 Sell 10 000 Peters William J Employee Stock Option (right to buy)
Nov 11, 2021 Sell 10 000 Peters William J Common Stock
Show all Insider Trades
INSIDER POWER

0.850

Last 100 transactions
Buy: 464 978 | Sell: 547 028 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 21.46 10.16 %
20.84 6.99 %
20.46 5.02 %
Current price: 19.48
Support 19.22 -1.33 %
18.84 -3.29 %
18.22 -6.47 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 21.18 8.73 %
21.15 8.57 %
20.76 6.57 %
Current price 19.48
Support 18.68 -4.11%
18.45 -5.29%
18.37 -5.70%

Click to get the best stock tips daily for free!

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable, inhalation, and intranasal products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company’s product portfolio comprises Enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treat... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT